Remdesivir

Cross-source consensus on Remdesivir from 1 sources and 5 claims.

1 sources · 5 claims

Uses

Remdesivir is available only as an intravenous formulation, making outpatient treatment logistically impractical. — COVID-19 ICU Treatment Protocols: Medications, Prone Positioning, and Emerging Evidence
Remdesivir is contraindicated in patients with significant renal impairment or elevated liver function tests. — COVID-19 ICU Treatment Protocols: Medications, Prone Positioning, and Emerging Evidence
Remdesivir received emergency FDA authorization based on a trial stopped early after demonstrating a recovery benefit and a trend toward mortality benefit. — COVID-19 ICU Treatment Protocols: Medications, Prone Positioning, and Emerging Evidence
Remdesivir showed the greatest clinical benefit in patients on nasal-cannula oxygen, with minimal benefit in patients already on mechanical ventilation. — COVID-19 ICU Treatment Protocols: Medications, Prone Positioning, and Emerging Evidence
Access to remdesivir was constrained by supply rationing rather than insurance decisions, with treatment reserved for patients already requiring supplemental oxygen. — COVID-19 ICU Treatment Protocols: Medications, Prone Positioning, and Emerging Evidence